Morton, C A <br/><br/>
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.  [electronic resource] 

 -  The British journal of dermatology  08 2018 
 - 309-319 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.16441  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Aged<br/>Aminolevulinic Acid--administration & dosage<br/>Carcinoma, Basal Cell--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Photochemotherapy--adverse effects<br/>Photosensitizing Agents--administration & dosage<br/>Skin--drug effects<br/>Skin Cream--administration & dosage<br/>Skin Neoplasms--drug therapy<br/>Treatment Outcome